Please login to the form below

Not currently logged in


This page shows the latest antiplatelet news and features for those working in and with pharma, biotech and healthcare.

UK heart deaths rise for first time in 50 years

UK heart deaths rise for first time in 50 years

Meanwhile, drug giants such as Novartis and AstraZeneca are developing new heart disease treatments, with the latter recently revealing that its antiplatelet drug Brilinta can reduce cardiovascular events in diabetes patients

Latest news

More from news
Approximately 3 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • Why health psychology is the answer to tackling adherence Why health psychology is the answer to tackling adherence

    In one recent programme that we developed on behalf of AstraZeneca, we assessed the reasons for low adherence in patients with acute coronary syndrome (ACS) who had been prescribed Oral Antiplatelet

  • Who tops the pharma list? Who tops the pharma list?

    The latter, an antiplatelet agent it co-marketed with Sanofi, enjoyed 2011 sales of $9.4bn - but, with Plavix accounting for more than a third of BMS revenues in 2010, the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...